Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1980 1
1983 1
1985 1
1987 1
1989 1
1991 1
1992 3
1993 2
1996 1
1997 1
1998 1
1999 2
2000 1
2002 3
2003 2
2004 2
2005 6
2006 4
2007 6
2008 14
2009 9
2010 21
2011 15
2012 23
2013 14
2014 10
2015 11
2016 22
2017 8
2018 17
2019 11
2020 11
2021 17
2022 13
2023 4
Text availability
Article attribute
Article type
Publication date

Search Results

229 results
Results by year
Filters applied: . Clear all
Page 1
Subsets of CD1c+ DCs: Dendritic Cell Versus Monocyte Lineage.
Heger L, Hofer TP, Bigley V, de Vries IJM, Dalod M, Dudziak D, Ziegler-Heitbrock L. Heger L, et al. Among authors: de vries ijm. Front Immunol. 2020 Sep 30;11:559166. doi: 10.3389/fimmu.2020.559166. eCollection 2020. Front Immunol. 2020. PMID: 33101275 Free PMC article. Review.
Tumor microenvironment shows an immunological abscopal effect in patients with NSCLC treated with pembrolizumab-radiotherapy combination.
van der Woude LL, Gorris MAJ, Wortel IMN, Creemers JHA, Verrijp K, Monkhorst K, Grünberg K, van den Heuvel MM, Textor J, Figdor CG, Piet B, Theelen WSME, de Vries IJM. van der Woude LL, et al. Among authors: de vries ijm. J Immunother Cancer. 2022 Oct;10(10):e005248. doi: 10.1136/jitc-2022-005248. J Immunother Cancer. 2022. PMID: 36252995 Free PMC article.
Mechanisms of Immune Checkpoint Inhibitor-Mediated Colitis.
Westdorp H, Sweep MWD, Gorris MAJ, Hoentjen F, Boers-Sonderen MJ, van der Post RS, van den Heuvel MM, Piet B, Boleij A, Bloemendal HJ, de Vries IJM. Westdorp H, et al. Among authors: de vries ijm. Front Immunol. 2021 Oct 29;12:768957. doi: 10.3389/fimmu.2021.768957. eCollection 2021. Front Immunol. 2021. PMID: 34777387 Free PMC article. Review.
PTEN Hamartoma Tumor Syndrome and Immune Dysregulation.
Eissing M, Ripken L, Schreibelt G, Westdorp H, Ligtenberg M, Netea-Maier R, Netea MG, de Vries IJM, Hoogerbrugge N. Eissing M, et al. Among authors: de vries ijm. Transl Oncol. 2019 Feb;12(2):361-367. doi: 10.1016/j.tranon.2018.11.003. Epub 2018 Nov 30. Transl Oncol. 2019. PMID: 30504085 Free PMC article. Review.
Innate Lymphoid Cells in Tumor Immunity.
van Beek JJP, Martens AWJ, Bakdash G, de Vries IJM. van Beek JJP, et al. Among authors: de vries ijm. Biomedicines. 2016 Feb 25;4(1):7. doi: 10.3390/biomedicines4010007. Biomedicines. 2016. PMID: 28536374 Free PMC article. Review.
Imaging of cellular therapies.
Srinivas M, Aarntzen EH, Bulte JW, Oyen WJ, Heerschap A, de Vries IJ, Figdor CG. Srinivas M, et al. Among authors: de vries ij. Adv Drug Deliv Rev. 2010 Aug 30;62(11):1080-93. doi: 10.1016/j.addr.2010.08.009. Epub 2010 Aug 25. Adv Drug Deliv Rev. 2010. PMID: 20800081 Review.
Migrating into the Tumor: a Roadmap for T Cells.
van der Woude LL, Gorris MAJ, Halilovic A, Figdor CG, de Vries IJM. van der Woude LL, et al. Among authors: de vries ijm. Trends Cancer. 2017 Nov;3(11):797-808. doi: 10.1016/j.trecan.2017.09.006. Epub 2017 Nov 6. Trends Cancer. 2017. PMID: 29120755 Review.
229 results